GHK-Cu: Comparing 50mg and 100mg Research Concentrations
GHK-Cu: Comparing 50mg and 100mg Research Concentrations
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide that has been extensively studied in preclinical models for its effects on skin biology, wound healing, and gene expression modulation. As research interest in GHK-Cu has grown, the compound has become available in multiple concentrations — most commonly 50mg and 100mg formulations. This article examines what the published research says about concentration-dependent effects and what factors researchers consider when selecting a concentration for laboratory use.
For a full overview of GHK-Cu, see our GHK-Cu deep-dive.
GHK-Cu: A Brief Recap
GHK-Cu was first identified by Dr. Loren Pickart in the 1970s from human plasma, where it was observed to promote hepatocyte proliferation in cell culture. The tripeptide (Gly-His-Lys) forms a complex with copper(II) ions at physiological pH, and this copper complex is the biologically active form.
Key mechanisms studied in preclinical research include:
- Gene expression modulation: In a landmark 2014 study, Pickart et al. demonstrated that GHK-Cu modulated the expression of over 4,000 human genes — approximately 6% of the human genome — with a net effect of shifting gene expression patterns toward profiles associated with younger tissue (Pickart et al., PLOS ONE, 2012; PMID: 23308016).
- Collagen and extracellular matrix: GHK-Cu has been observed to stimulate collagen synthesis, fibronectin production, and glycosaminoglycan deposition in fibroblast cultures.
- Antioxidant enzyme induction: The peptide has been associated with upregulation of superoxide dismutase (SOD) and other endogenous antioxidant enzymes.
Concentration in Published Research
The published literature on GHK-Cu uses a wide range of concentrations depending on the experimental model:
Cell culture studies: In vitro studies have typically examined GHK-Cu at concentrations ranging from 1 nM to 10 µM. Many of the seminal gene expression and collagen synthesis studies used concentrations in the 1–10 µM range, which is near the estimated physiological concentration of GHK in young adult plasma (~200 ng/mL, approximately 0.5 µM) (Pickart, Journal of Biomaterials Science, Polymer Edition, 2008; PMID: 18925866).
Animal studies: In vivo wound healing studies in rodent models have used varying total doses, typically administered topically in hydrogel or cream formulations. The concentration in these formulations varies widely across publications.
Dose-response observations: In cell culture models, GHK-Cu effects on fibroblast proliferation and collagen synthesis have been observed to follow a dose-response curve, with optimal effects in a defined concentration range. Very high concentrations did not necessarily produce proportionally greater effects — consistent with receptor saturation or feedback dynamics common in biological systems.
50mg vs 100mg: Practical Research Considerations
The 50mg and 100mg designations refer to the total amount of GHK-Cu peptide in a vial. The actual concentration used in any experiment depends on how the researcher reconstitutes and dilutes the material. Some practical considerations:
Reconstitution flexibility: A 100mg vial provides more material for experiments requiring higher total amounts or multiple experimental runs, while a 50mg vial may be more appropriate for smaller-scale studies or initial concentration-finding experiments.
Storage and stability: GHK-Cu is relatively stable as a lyophilized powder but may degrade after reconstitution, particularly in the presence of copper-chelating agents or at elevated temperatures. Larger vials that are repeatedly accessed after reconstitution may experience more degradation over time compared to smaller vials that are used in fewer aliquoting sessions.
Cost efficiency: For researchers who have already established their optimal working concentration and require larger quantities, the 100mg formulation typically offers better value per milligram. For exploratory studies or researchers new to GHK-Cu, the 50mg formulation provides sufficient material for concentration-finding experiments without committing to a larger quantity.
Blend formulations: GHK-Cu is also available in blend formulations that combine it with other peptides. CALM Peptides offers the GLOW Blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) and the KLOW Blend (GHK-Cu 50mg + KPV 10mg + BPC-157 10mg + TB-500 10mg) for multi-compound research protocols.
Available for Research
CALM Peptides offers research-grade GHK-Cu with third-party purity verification. Certificates of Analysis are available upon request. Browse all skin peptides or explore our full catalog.
Frequently Asked Questions
What concentration of GHK-Cu is used in published research?
Published studies use concentrations ranging from 1 nM to 10 µM in cell culture, with many key studies in the 1–10 µM range. The physiological concentration in young adult plasma is estimated at approximately 0.5 µM. In vivo studies use varying total doses depending on the model and delivery method.
Does doubling the concentration double the effect?
Not necessarily. Like most bioactive compounds, GHK-Cu has been observed to follow a dose-response curve in cell culture models, with optimal effects within a defined concentration range. Effects do not increase linearly with concentration, consistent with receptor saturation and feedback mechanisms.
Should I choose 50mg or 100mg for my research?
This depends on your experimental design. The 50mg formulation is suitable for smaller-scale or exploratory studies. The 100mg formulation offers better per-milligram value for researchers with established protocols requiring larger quantities or multiple experimental runs.
What is the difference between GHK-Cu and the GLOW or KLOW blends?
GHK-Cu standalone contains only the copper peptide complex. The GLOW Blend adds BPC-157 and TB-500, while the KLOW Blend adds KPV, BPC-157, and TB-500. These blends are designed for researchers studying multiple compounds in parallel.
The information presented in this article is for educational and informational purposes only and is not intended as medical advice. GHK-Cu is sold as a research chemical for laboratory use only. It is not intended for human consumption, and should not be used to diagnose, treat, cure, or prevent any disease. All references to published research are provided for informational context. Consult qualified professionals for guidance related to any health condition.
For research use only. Not for human consumption.
The information presented in this article is for educational and informational purposes only and is not intended as medical advice. All products referenced are sold as research chemicals for laboratory use only. They are not intended for human consumption and should not be used to diagnose, treat, cure, or prevent any disease. All references to published research are provided for informational context. Consult qualified professionals for guidance related to any health condition.